SINT Stock Analysis: Buy, Sell, or Hold?
SINT - SiNtx Technologies, Inc. Common Stock
$1.71
0.14 (8.92%)
▲
5d:
+4.91%
30d:
+8.92%
90d:
-28.15%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When SINT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SINT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SINT shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SINT is currently trading at $1.71, which is considered extended relative to its 30-day fair value range of $1.52 to $1.75.
Technical Outlook: Technically, SINT is in a strong downtrend. Immediate support is located at $1.51, while resistance sits at $1.90. The stock is showing strong short-term momentum, up 8.9% recently.
Market Sentiment: SINT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.12 (+433.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SINT is in a strong downtrend. Immediate support is located at $1.51, while resistance sits at $1.90. The stock is showing strong short-term momentum, up 8.9% recently.
Market Sentiment: SINT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.12 (+433.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.52 -
$1.75
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
31.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.9%)
- BULLISH: Trading 433.6% below Wall St target ($9.12)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.52 -
$1.75
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.51
Resistance Level
$1.90
Current Trend
Strong Downtrend
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.19
Wall Street Target
$9.13
(+433.6%)
Revenue Growth (YoY)
3.0%
Share & Embed Analysis
Last updated: August 13, 2026 11:02 PM ET
Data refreshes hourly during market hours. Next update: 12:02 AM
Data refreshes hourly during market hours. Next update: 12:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SINT showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Christopher Michael Lyons
BUY
7534 shares
2026-03-02
Christopher Michael Lyons
BUY
758 shares
2026-02-25
Jay M Moyes
BUY
1000 shares
2026-02-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 33 SELL |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$382 | 50 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 34 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 36 SELL |
